Identification of 1H-pyrazolo[3,4-b]pyridines as potential inhibitors of Leishmania arginase
Leishmaniasis, a parasitic disease transmitted by sandflies, remains a significant global health concern, particularly in tropical regions. The arginase enzyme ( La Arg) has emerged as a promising therapeutic target in Leishmania amazonensis . This study employs a computer-aided drug design approach to identify novel La Arg inhibitor candidates. A series of 38 compounds featuring a 1 H -pyrazolo[3,4- b ]pyridine nucleus was evaluated using 3D-QSAR (Py-CoMFA), molecular docking, and molecular dynamics simulations to predict pIC 50 values and investigate molecular interactions within the La Arg active site. Our results identified 14 compounds with promising predicted activity (pIC 50 ≥ 5.00). Molecular docking analysis revealed that 10 compounds establish strong interactions with key catalytic residues (His127 and His142) and Mn 2+ ions, which are crucial for La Arg binding. Molecular dynamics further characterized compounds 1b and 1e as potential arginase inhibitors, though they exhibited distinct thermodynamic profiles. Compound 1b , featuring a nitrile group, demonstrated initial stability and a balanced molecular profile. However, it failed to maintain its binding mode throughout the entire simulation trajectory. Conversely, while 1e remained stable at the site, its bromine substituent incurred a significant solvation penalty, leading to a less favorable binding free energy than 1b . These findings provide significant insights into the structural requirements for arginase inhibition and establish a framework for developing novel therapeutic compounds against leishmaniasis.
Authors
- Joana Lucius de Sousa Ribeiro (ORCID: https://orcid.org/0000-0002-1480-2982)
- Priscila Goes Camargo (ORCID: https://orcid.org/0000-0003-4483-2119)
- Luiza R.S. Dias (ORCID: https://orcid.org/0000-0001-5809-5602)
- Carlos Rangel Rodrigues (ORCID: https://orcid.org/0000-0001-8453-7654)
- Magaly Girão Albuquerque (ORCID: https://orcid.org/0000-0003-1558-0928)
- Camilo Henrique da Silva Lima (ORCID: https://orcid.org/0000-0002-5579-7809)
- Júlio César de Araujo Vanelis Soares (ORCID: https://orcid.org/0000-0002-2125-9850)
- Carine Ribeiro dos Santos (ORCID: https://orcid.org/0000-0002-6436-9101)
- Estela M.F. Muri (ORCID: https://orcid.org/0000-0001-8489-1848)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal Fluminense (BR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41598-026-76684-6
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Centro Nacional de Processamento de Alto Desempenho em São Paulo